A novel plasmid-based co-tethered transcription platform for high yield, high purity mRNA synthesis
Nucleic Acids Research · 2025
DOI: 10.1093/nar/gkaf1355 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acids Research, 2025. Verfasst von Purnima Mala und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, University of Massachusetts Amherst, 710 N Pleasant St, Amherst, MA 01003, United States. Hauptthemen laut MEDLINE: RNA, Messenger, Plasmids, Transcription, Genetic, DNA-Directed RNA Polymerases. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHGRI NIH HHS, NIH HHS, University of Massachusetts.
Abstract (Originalsprache)
This work aims to improve RNA synthesis and manufacturing, exemplified by T7 RNA polymerase-driven in vitro transcription. We developed a novel, plasmid-compatible co-tethering strategy that functionally couples RNA polymerase to its promoter DNA immobilized on a solid matrix. As demonstrated recently, co-tethering enhances promoter binding, increases RNA yield, and suppresses RNA re-binding, especially under high-salt conditions, thereby reducing double-stranded RNA by-products. The system leverages asymmetric end-labeling of linearized plasmid DNA using a simple “Klenow fill-in” reaction with modified nucleotides, enabling stable attachment of DNA to both RNA polymerase and solid support (magnetic beads). The immobilized co-tethered polymerase–DNA complex supports efficient transcription initiation in high-salt environments (which further reduces RNA re-binding), yielding RNA of high purity. Co-tethered complex remains functionally stable over extended storage and multiple transcription cycles (10-20 rounds), re-using the enzyme–DNA catalyst. Transcripts of lengths (0.8, 5.6, and 8.6 kb) are efficiently produced. Highly sensitive in vitro assays with immune cells confirm low immunogenicity and strong translational output, while in vivo validation using a novel Matrigel-plugged mouse model demonstrates robust expression and safety. With a simple modification to the DNA template, the reusable, co-tethered enzyme–DNA catalytic complex streamlines mRNA manufacturing by producing RNA of higher purity from the outset.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, University of Massachusetts Amherst, 710 N Pleasant St, Amherst, MA 01003, United States.
- Department of Chemical Biomolecular Engineering, University of Massachusetts Amherst, 686 North Pleasant StreetAmherst, MA 01003, United States.
ORCID-Profile: Ruptanu Banerjee, Craig T Martin
Förderung
- NHGRI NIH HHS
- NIH HHS
- University of Massachusetts
- National Research Service Award
- NIGMS NIH HHS
- Wellcome Leap
- National Institutes of Health
Zitieren
APA
Mala, P., Banerjee, R., Abek, A., Forster Iii, J., Pinjari, A., Kulkarni, A. A., & Martin, C. T. (2025). A novel plasmid-based co-tethered transcription platform for high yield, high purity mRNA synthesis. Nucleic Acids Research. https://doi.org/10.1093/nar/gkaf1355
Vancouver
Mala P, Banerjee R, Abek A, Forster Iii J, Pinjari A, Kulkarni AA, et al. A novel plasmid-based co-tethered transcription platform for high yield, high purity mRNA synthesis. Nucleic Acids Research. 2025. doi:10.1093/nar/gkaf1355
BibTeX
@article{Mala2025,
author = {Mala, Purnima and Banerjee, Ruptanu and Abek, Amin and Forster Iii, James and Pinjari, Aniruddha and Kulkarni, Ashish A and Martin, Craig T},
title = {A novel plasmid-based co-tethered transcription platform for high yield, high purity mRNA synthesis},
journal = {Nucleic Acids Research},
year = {2025},
doi = {10.1093/nar/gkaf1355}
}
EUVIMED